Back
Open Access

GLP-1RAs: what does the future hold?

Session: A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future
Topic: Obesity and Diabetes
Speaker: Doctor T. Vilsboll (Copenhagen, DK)
Sponsored by Novo Nordisk
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tina Vilsboll

Copenhagen University Hospital, Copenhagen (Denmark)
5 presentations
0 follower

5 more presentations in this session

Welcome and introductions: cardiovascular risk in people with type 2 diabetes and/or obesity

Speaker: Professor N. Marx (Aachen, DE)

Access
Thumbnail

The effect of GLP-1RAs on cardiovascular disease and cardio-metabolic risk factors in patients with obesity and/or type 2 diabetes

Speaker: Professor S. Verma (Toronto, CA)

Access
Thumbnail

A focus on the practical: how can cardiologists best utilise GLP-1RAs in the clinic?

Speaker: Professor N. Marx (Aachen, DE)

Access
Thumbnail

Panel discussion and Q&A

Access
Thumbnail

Closing

Speaker: Professor N. Marx (Aachen, DE)

Access
Thumbnail

Access the full session

A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

Speakers: Doctor T. Vilsboll, Professor N. Marx, Professor S. Verma, Professor N. Marx, Professor N. Marx
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb